Last reviewed · How we verify
N-acetylcysteine 1000 mg
N-acetylcysteine 1000 mg is a Small molecule drug developed by Pontificia Universidad Catolica de Chile. It is currently FDA-approved. Also known as: Mucolítico, Sanitas, Chile.
At a glance
| Generic name | N-acetylcysteine 1000 mg |
|---|---|
| Also known as | Mucolítico, Sanitas, Chile |
| Sponsor | Pontificia Universidad Catolica de Chile |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32) (NA)
- Evaluation of the Role of N Acetyl Cysteine and Vitamin D in Improving Outcomes After Corrosive Ingestion (PHASE3)
- A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery (PHASE3)
- Efficacy Study of a Food Supplement With Myo-inositol, N-Acetyl-Cystein, Zinc and Vitamins on Sperm DNA Fragmentation (NA)
- N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients (PHASE2)
- Using Acetylcysteine and Vitamin E With Psoriasis Vulgaris (PHASE3)
- Granulocyte Colony Stimulating Factor Four Week Plus N-Acetyl Cysteine in Severe Alcoholic Hepatitis (PHASE4)
- N-Acetylcysteine as an Adjuvant Therapy in Critically Ill COVID-19 Patients:
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- N-acetylcysteine 1000 mg CI brief — competitive landscape report
- N-acetylcysteine 1000 mg updates RSS · CI watch RSS
- Pontificia Universidad Catolica de Chile portfolio CI
Frequently asked questions about N-acetylcysteine 1000 mg
What is N-acetylcysteine 1000 mg?
N-acetylcysteine 1000 mg is a Small molecule drug developed by Pontificia Universidad Catolica de Chile.
Who makes N-acetylcysteine 1000 mg?
N-acetylcysteine 1000 mg is developed and marketed by Pontificia Universidad Catolica de Chile (see full Pontificia Universidad Catolica de Chile pipeline at /company/pontificia-universidad-catolica-de-chile).
Is N-acetylcysteine 1000 mg also known as anything else?
N-acetylcysteine 1000 mg is also known as Mucolítico, Sanitas, Chile.
What development phase is N-acetylcysteine 1000 mg in?
N-acetylcysteine 1000 mg is FDA-approved (marketed).
Related
- Manufacturer: Pontificia Universidad Catolica de Chile — full pipeline
- Also known as: Mucolítico, Sanitas, Chile
- Compare: N-acetylcysteine 1000 mg vs similar drugs
- Pricing: N-acetylcysteine 1000 mg cost, discount & access